Tradeweb Markets Inc.
TW Nasdaq Security & Commodity Brokers, Dealers, Exchanges & Services Financials FY2017βFY2025
What Tradeweb Markets Inc. does
No business description yet.
- Legal name
- Tradeweb Markets Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 5, 2026
- Accession Β· CIK
- 0001758730-26-000015
0001758730
Revenue and margins
Tradeweb Markets Inc. had $2.1B of revenue in fiscal 2025, up 18.9% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $1.1B in fiscal 2025, 54.9% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Tradeweb Markets Inc. returned $104M to shareholders in fiscal 2025, 9% of free cash flow. The diluted share count fell 0.0%.
Balance sheet
Cash, debt and the ratios that show how comfortably Tradeweb Markets Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $972M | $1.3B | $1.7B | $1.3B | $2.1B |
| Interest coverage | β | 228.6x | 246.8x | 158.5x | 430.4x |
| Total assets | $6.0B | $6.3B | $7.1B | $7.3B | $8.2B |
| Total liabilities | $681M | $714M | $1.1B | $869M | $1.0B |
| Shareholders' equity | $4.6B | $5.0B | $5.4B | $5.8B | $6.5B |
| Net debt (β = net cash) | β | β | β | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY17 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β |
| F-score | β / 3 | β / 3 | β / 6 | β / 6 | β / 6 | β / 6 | β / 6 |
| Accruals ratio | β | β5.1% | β6.0% | β5.3% | β5.7% | β5.5% | β4.6% |
| Altman Z'' | β | β | β | β | β | β | β |
8 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY17 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $504M | β | $893M | $1.1B | $1.2B | $1.3B | $1.7B | $2.1B |
| Net interest income | β | β | β$0.3M | β$1.6M | $11.9M | $65.4M | β | β |
| Operating income | $89.1M | β | $263M | $359M | $413M | $505M | $678M | $835M |
| Interest expense | β | β | β | β | $1.8M | $2.0M | $4.3M | $1.9M |
| Pretax income | $89.8M | β | $274M | $370M | $437M | $548M | $754M | $1.2B |
| Income tax | $6.1M | β | $56.1M | $96.9M | $77.5M | $128M | $184M | $253M |
| Net income | $83.6M | β | $166M | $227M | $309M | $365M | $502M | $813M |
| Net income to common | β | β | $166M | $227M | $309M | $364M | $501M | $812M |
| Diluted EPS | β | β | $0.88 | $1.09 | $1.48 | $1.71 | $2.33 | $3.78 |
| Diluted shares | 0.22B | β | 0.19B | 0.21B | 0.21B | 0.21B | 0.21B | 0.21B |
| Cash flow | ||||||||
| Cash from operations | $225M | β | $443M | $578M | $633M | $746M | $898M | $1.2B |
| Capital expenditure | $13.5M | β | $11.5M | $16.9M | $23.2M | $18.5M | $41.0M | $40.6M |
| Free cash flow | $211M | β | $432M | $561M | $610M | $728M | $857M | $1.1B |
| Depreciation and amortization | $68.6M | β | $154M | $171M | $179M | $185M | $220M | $250M |
| Stock-based compensation | $26.1M | β | $39.3M | $51.9M | $66.6M | $65.1M | $89.6M | $104M |
| Acquisitions | β | β | $0.0M | $208M | $0.0M | $69.7M | $860M | $0.0M |
| Share buybacks | β | β | $0.0M | $75.7M | $99.3M | $35.2M | $59.1M | $104M |
| Dividends and buybacks | β | β | $0.0M | $75.7M | $99.3M | $35.2M | $59.1M | $104M |
| Balance sheet | ||||||||
| Cash and short-term investments | $354M | $461M | $791M | $972M | $1.3B | $1.7B | $1.3B | $2.1B |
| Property and equipment, net | β | $40.4M | $33.8M | $31.1M | $37.4M | $33.6M | $46.0M | $78.2M |
| Goodwill | β | $2.7B | $2.7B | $2.8B | $2.8B | $2.8B | $3.2B | $3.2B |
| Intangible assets | β | $1.3B | $1.2B | $1.2B | $1.1B | $1.0B | $1.3B | $1.1B |
| Total assets | β | $5.1B | $5.7B | $6.0B | $6.3B | $7.1B | $7.3B | $8.2B |
| Total liabilities | β | $503M | $661M | $681M | $714M | $1.1B | $869M | $1.0B |
| Preferred stock | β | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Shareholders' equity | β | $3.4B | $4.3B | $4.6B | $5.0B | $5.4B | $5.8B | $6.5B |
| Margins | ||||||||
| Operating margin | 17.7% | β | 29.5% | 33.3% | 34.7% | 37.8% | 39.3% | 40.7% |
| EBITDA margin | 31.3% | β | 46.7% | 49.2% | 49.8% | 51.6% | 52.0% | 52.9% |
| Net margin | 16.6% | β | 18.6% | 21.1% | 26.0% | 27.3% | 29.1% | 39.6% |
| FCF margin | 41.9% | β | 48.4% | 52.1% | 51.3% | 54.4% | 49.6% | 54.9% |
| Net interest share of revenue | β | β | β0.0% | β0.1% | 1.0% | 4.9% | β | β |
| Returns | ||||||||
| Return on equity | β | β | 4.3% | 5.1% | 6.4% | 7.1% | 9.0% | 13.2% |
| Return on assets | β | β | 3.1% | 3.9% | 5.1% | 5.5% | 7.0% | 10.5% |
| Return on tangible equity | β | β | 39.0% | 33.1% | 28.1% | 23.5% | 36.6% | 36.8% |
| Growth | ||||||||
| Revenue growth | β | β | β | 20.6% | 10.4% | 12.6% | 29.0% | 18.9% |
| Net income growth | β | β | β | 36.4% | 36.4% | 18.0% | 37.4% | 62.1% |
| EPS growth | β | β | β | 23.9% | 35.8% | 15.5% | 36.3% | 62.2% |
| FCF growth | β | β | β | 30.0% | 8.6% | 19.3% | 17.8% | 31.5% |
| Share count change | β | β | β | 10.1% | 0.6% | 2.0% | 1.1% | β0.0% |
| Financial health | ||||||||
| Interest coverage | β | β | β | β | 228.6x | 246.8x | 158.5x | 430.4x |
| Capital allocation | ||||||||
| Capex / revenue | 2.7% | β | 1.3% | 1.6% | 2.0% | 1.4% | 2.4% | 2.0% |
| Stock comp / revenue | 5.2% | β | 4.4% | 4.8% | 5.6% | 4.9% | 5.2% | 5.0% |
| Payouts / FCF | β | β | 0.0% | 13.5% | 16.3% | 4.8% | 6.9% | 9.2% |
| Quality scores | ||||||||
| Accruals ratio | β | β | β5.1% | β6.0% | β5.3% | β5.7% | β5.5% | β4.6% |
Source: SEC EDGAR XBRL filings (CIK 0001758730). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.